| Hospice Of Hope 501 E 6th Street, Texarkana, AR, 71854 | |
| (870) 216-0046 |
News Archive
Before stem cells, of whatever origin, can be used to treat patients, scientists will need to learn how to coax them to develop into the desired cell types, a major challenge.
Immunosuppressed patients with sepsis appear more likely to die if they are treated in a hospital caring for a relatively small number of these patients, according to new research published online in the Annals of the American Thoracic Society.
Al Jazeera examines maternal mortality worldwide, saying, "If the situation continues at its current rate, the world will not meet" the U.N. Millennium Development Goal "to reduce maternal mortality by 75 percent between 1990 and 2015."
The study, published on the preprint server medRxiv, explores the ability of HLA class I molecules to mediate the outcome in COVID-19 patients.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's earnings within twelve months.
› Verified 2 days ago
| Name | Hospice Of Hope |
|---|---|
| Location | 501 E 6th Street, Texarkana, Arkansas |
| Hospice ID | 041535 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Other |
| Profit Type | NON-PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 450 |
News Archive
Before stem cells, of whatever origin, can be used to treat patients, scientists will need to learn how to coax them to develop into the desired cell types, a major challenge.
Immunosuppressed patients with sepsis appear more likely to die if they are treated in a hospital caring for a relatively small number of these patients, according to new research published online in the Annals of the American Thoracic Society.
Al Jazeera examines maternal mortality worldwide, saying, "If the situation continues at its current rate, the world will not meet" the U.N. Millennium Development Goal "to reduce maternal mortality by 75 percent between 1990 and 2015."
The study, published on the preprint server medRxiv, explores the ability of HLA class I molecules to mediate the outcome in COVID-19 patients.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's earnings within twelve months.
› Verified 2 days ago
| NPI Number | 1548268683 |
| Organization Name | Hospice Of Hope |
| Address | 501 E 6th St Texarkana, Arkansas, 71854 |
| Phone Number | (870)216-0046 |
News Archive
Before stem cells, of whatever origin, can be used to treat patients, scientists will need to learn how to coax them to develop into the desired cell types, a major challenge.
Immunosuppressed patients with sepsis appear more likely to die if they are treated in a hospital caring for a relatively small number of these patients, according to new research published online in the Annals of the American Thoracic Society.
Al Jazeera examines maternal mortality worldwide, saying, "If the situation continues at its current rate, the world will not meet" the U.N. Millennium Development Goal "to reduce maternal mortality by 75 percent between 1990 and 2015."
The study, published on the preprint server medRxiv, explores the ability of HLA class I molecules to mediate the outcome in COVID-19 patients.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's earnings within twelve months.
› Verified 2 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.2 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 94.5 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 45.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 97.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | 99.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Before stem cells, of whatever origin, can be used to treat patients, scientists will need to learn how to coax them to develop into the desired cell types, a major challenge.
Immunosuppressed patients with sepsis appear more likely to die if they are treated in a hospital caring for a relatively small number of these patients, according to new research published online in the Annals of the American Thoracic Society.
Al Jazeera examines maternal mortality worldwide, saying, "If the situation continues at its current rate, the world will not meet" the U.N. Millennium Development Goal "to reduce maternal mortality by 75 percent between 1990 and 2015."
The study, published on the preprint server medRxiv, explores the ability of HLA class I molecules to mediate the outcome in COVID-19 patients.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's earnings within twelve months.
› Verified 2 days ago
| Home Health Aides | 2.75 |
| Counselors | 0.4 |
| Homemakers | 0.25 |
| Licensed Practical or Vocational Nurses | 2.6 |
| Medical Social Workers | 0.8 |
| Physicians | 0.15 |
| Registered Nurses | 6.6 |
| Total Employees | 13.55 |
|---|
News Archive
Before stem cells, of whatever origin, can be used to treat patients, scientists will need to learn how to coax them to develop into the desired cell types, a major challenge.
Immunosuppressed patients with sepsis appear more likely to die if they are treated in a hospital caring for a relatively small number of these patients, according to new research published online in the Annals of the American Thoracic Society.
Al Jazeera examines maternal mortality worldwide, saying, "If the situation continues at its current rate, the world will not meet" the U.N. Millennium Development Goal "to reduce maternal mortality by 75 percent between 1990 and 2015."
The study, published on the preprint server medRxiv, explores the ability of HLA class I molecules to mediate the outcome in COVID-19 patients.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's earnings within twelve months.
› Verified 2 days ago
| Physicians | 0.05 |
| Others | 17 |
| Total Volunteers | 17.05 |
|---|
News Archive
Before stem cells, of whatever origin, can be used to treat patients, scientists will need to learn how to coax them to develop into the desired cell types, a major challenge.
Immunosuppressed patients with sepsis appear more likely to die if they are treated in a hospital caring for a relatively small number of these patients, according to new research published online in the Annals of the American Thoracic Society.
Al Jazeera examines maternal mortality worldwide, saying, "If the situation continues at its current rate, the world will not meet" the U.N. Millennium Development Goal "to reduce maternal mortality by 75 percent between 1990 and 2015."
The study, published on the preprint server medRxiv, explores the ability of HLA class I molecules to mediate the outcome in COVID-19 patients.
Solta Medical, Inc., a global leader in the medical aesthetics market, today announced it has entered into a definitive agreement to acquire privately-held Aesthera Corporation, which is based in Pleasanton, California. Under the terms of the definitive agreement, Solta will acquire Aesthera for $5.25 million in Solta common stock and cash, with potential additional base line milestones of $750,000 for a consideration of $6.0 million. Excluding acquisition and integration related charges, the transaction is expected to be accretive to Solta Medical's earnings within twelve months.
› Verified 2 days ago
| Encompass Hospice Of Texarkana Location: 210 North Stateline, Suite 301, Texarkana, Arkansas, 71854 Phone: (870) 216-0046 |
| Kindred Hospice I Location: 210 N Stateline Avenue, Suite 504b, Texarkana, Arkansas, 71854 Phone: (870) 216-0046 |
| Hospice Of Hope Location: 501 E 6th Street, Texarkana, Arkansas, 71854 Phone: (870) 216-0046 |
| Dierksen Memorial Hospice Location: 4425 Jefferson Boulevard, Suite 104, Texarkana, Arkansas, 71854 Phone: (870) 216-0046 |